About Confira Laboratories Private Limited
Data last updated: 12 March 2026
Confira Laboratories Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Encube Ethicals Private Limited. It specialises in health and beauty retail and distribution, a part of the broader consumer goods sector. Incorporated on 14 January 2019, the company has been in operation for over 7 years.
Registered with ROC Mumbai under CIN U24290MH2019PTC319509.
Capital: an authorised share capital of ₹11 Cr and a paid-up capital of ₹9.33 Cr. It is led by directors including Mehul Madhusudan Shah and Niloni Mehul Shah.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.51 Cr, reflecting significant growth compared to the previous year.
It operates as a subsidiary of Encube Ethicals Private Limited.
The company is associated with 2 brands - The Pink Foundry, Confiralabs.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website confiralabs.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media**************
-
Registered Address804 B Wing 8Th Floor Hdil Kaledonia, Sahar Road, Mumbai, Maharashtra, India – 400069
-
IndustryConsumer Goods, Health & Beauty Retail & Distribution
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Confira Laboratories Private Limited
Confira Laboratories Private Limited operates two associated brands: The Pink Foundry and Confiralabs. These brands represent Confira Laboratories Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Offers online skincare solutions for acne, dark spots, and hydration needs. | thepinkfoundry.com | |
| Cosmetic solutions, beauty formulations, and compliance services in India. | confiralabs.com |
Competitors & Alternatives of Confira Laboratories Private Limited
Brands and companies operating in the same space as Confira Laboratories Private Limited include Dot & Key, RAS Luxury Oils, Clayco and 4 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Dot & Key
|
Internet-first brand of natural skincare products | Kolkata, India, India | 2018 |
RAS Luxury Oils
|
Online luxury beauty brand offering multi-category organic skincare products | Raipur, India, India | 2017 |
Clayco
|
Platform offering skincare products | Mumbai, India, India | 2023 |
Aminu
|
Offers balanced skincare solutions for various concerns like aging and hydration. | Mumbai, India, India | 2019 |
Cosmetofood
|
Brand offering skin care products | Gurugram, India, India | 2018 |
Himaira
|
Provides natural skincare solutions including face care and body products online. | New Delhi, India, India | 2019 |
Sereko
|
Provides skincare and nutrition products addressing mental stress and skin issues. | Noida, India, India | 2021 |
Business Activity of Confira Laboratories Private Limited
Confira Laboratories Private Limited is engaged in the principal business activity of trade, with detailed activities including retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | ********* |
Auditor Details of Confira Laboratories Private Limited
Confira Laboratories Private Limited is audited by Shaparia Mehta & Associates Llp for the financial year 2021. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Shaparia Mehta & Associates Llp | blur-value | blur-value | blur-value |
Board of Directors of Confira Laboratories Private Limited
Confira Laboratories Private Limited is currently managed by 3 directors, with 1 former director having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mehul Madhusudan Shah | Director | 14 Jan 2019 | 7 Years 5 Months | Current |
| Niloni Mehul Shah | Managing Director | 09 May 2023 | 3 Years 2 Months | Current |
| Niti Mehul Shah | Director | 14 Jan 2019 | 7 Years 5 Months | Current |
Financials of Confira Laboratories Private Limited FY 2025 filings available
Confira Laboratories Private Limited reported revenue of ₹9.51 Cr (up 183% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Confira Laboratories Private Limited
As of FY 2022, Confira Laboratories Private Limited's shareholding pattern shows 97.59% by promoters, 2.41% by public shareholders. The promoters hold a majority stake, indicating strong promoter control.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Charges & Borrowings Confira Laboratories Private Limited
Confira Laboratories Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Confira Laboratories Private Limited
View historical data on people associated with Confira Laboratories Private Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Confira Laboratories Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Confira Laboratories Private Limited
GSTIN & GST Filing Data of Confira Laboratories Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Confira Laboratories Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Confira Laboratories Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Confira Laboratories Private Limited
MSME Payment Delays by Confira Laboratories Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Confira Laboratories Private Limited
Subsidiaries & Group Companies of Confira Laboratories Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Confira Laboratories Private Limited with ownership details.
MCA Filings & Documents of Confira Laboratories Private Limited
MCA Filings & Documents of Confira Laboratories Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Confira Laboratories Private Limited
Frequently Asked Questions about Confira Laboratories Private Limited
Confira Laboratories Private Limited is an active private limited company in the consumer goods sector based in Mumbai, Maharashtra, India. It was incorporated on 14 January 2019 (7+ years old) and is registered under CIN U24290MH2019PTC319509.
Confira Laboratories Private Limited reported revenue of ₹9.51 Cr for FY 2025 (up 183.00% YoY).
The current directors of Confira Laboratories Private Limited are:
The primary industry of Confira Laboratories Private Limited is consumer goods. The company specifically operates in health and beauty retail and distribution. The company is currently active in this sector.
Confira Laboratories Private Limited can be reached at the registered office: 804 B Wing 8Th Floor Hdil Kaledonia, Sahar Road, Mumbai, Maharashtra, India – 400069, or through the website confiralabs.com.
The authorised capital is ₹11 Cr, and the paid-up capital is ₹9.33 Cr.